Bevacizumab treatment for retinopathy of prematurity in South Africa | Pollock | South African Medical Journal

Editorial

Bevacizumab treatment for retinopathy of prematurity in South Africa

T Pollock

Author's affiliations

T Pollock, Division of Ophthalmology, Red Cross War Memorial Children’s Hospital and University of Cape Town, South Africa

Full Text

PDF (60KB)

Keywords

Bevacizumab; Retinopathy of prematurity; South Africa

Cite this article

South African Medical Journal 2017;107(3):178-179. DOI:10.7196/SAMJ.2017.v107i3.12388

Article History

Date submitted: 2017-02-27
Date published: 2017-02-27

Article Views

Abstract views: 1206
Full text views: 1105

Comments on this article

*Read our policy for posting comments here

The South African Medical Journal | Online ISSN: 2078-5135 | Print ISSN: 0256-9574 | © 2014 Health & Medical Publishing Group

This journal is protected by a Creative Commons Attribution - NonCommercial Works License (CC BY-NC 4.0) | Read our privacy policy.

Our Journals: South African Medical Journal | African Journal of Health Professions Education | South African Journal of Bioethics and Law | South African Journal of Child Health | Southern African Journal of Critical Care | South African Journal of Obstetrics and Gynaecology |